We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation.
- Authors
Eisenstein, Eric L.; Anstrom, Kevin J.; Kong, David F.; Shaw, Linda K.; Tuttle, Robert H.; Mark, Daniel B.; Kramer, Judith M.; Harrington, Robert A.; Matchar, David B.; Kandzari, David E.; Peterson, Eric D.; Schulman, Kevin A.; Califf, Robert M.
- Abstract
The article discusses a clinical study that was conducted to examine the association between the use of the drug clopidogrel after patients received either a drug-eluting stent or a bare-metal stent for the treatment of coronary artery disease. Clopidogrel is a drug used in thienopyridine antiplatelet therapy to prevent late stent thrombosis. The authors were interested in the long-term outcomes of patients and found that the use of clopidogrel in patients with drug-eluting stents may be associated with a lower risk of death or myocardial infarction.
- Subjects
SURGICAL stents; CORONARY heart disease treatment; THROMBOSIS prevention; THERAPEUTICS; HEART diseases; COMPLICATIONS of cardiac surgery; CLINICAL medicine research; PREVENTION
- Publication
JAMA: Journal of the American Medical Association, 2007, Vol 297, Issue 2, p159
- ISSN
0098-7484
- Publication type
Article
- DOI
10.1001/jama.297.2.joc60179